Sign In
Buy CODX
$1.44
-0.120 (-7.69%)
At Close: Jul 31, 2026
Co-Diagnostics, Inc. to Present at Sidoti Virtual Investor Conference
05:03pm, Monday, 20'th Sep 2021
SALT LAKE CITY, Sept. 20, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, a
Co-Diagnostics says its CoSara JV received regulatory clearance in India for Saragene dengue and chikungunya tests
01:42pm, Thursday, 16'th Sep 2021
Co-Diagnostics (NASDAQ:CODX) Inc has announced that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received clearance from the Central Drugs Standard Control
Co-Diagnostics says its CoSara JV received regulatory clearance in India for Saragene dengue and chikunguny tests
10:36am, Thursday, 16'th Sep 2021
Co-Diagnostics Inc has announced that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received clearance from the Central Drugs Standard Control Organization (
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests
09:30am, Thursday, 16'th Sep 2021
SALT LAKE CITY, Sept. 16, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular
Co-Diagnostics says its Logix Smart COVID-19 Test Kit used to confirm presence of coronavirus including mutated strains in Italy
10:25am, Wednesday, 08'th Sep 2021
Co-Diagnostics Inc. reports that its Logix Smart COVID-19 Test Kit was used by Italian researchers to confirm the presence of SARS-CoV-2, including mutated strains of the virus.
Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy
09:30am, Wednesday, 08'th Sep 2021
SALT LAKE CITY, Sept. 8, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced t
Why Co-Diagnostics Is A Solid Covid-19 Play
01:54am, Thursday, 19'th Aug 2021
Why Co-Diagnostics Is A Solid Covid-19 Play
CoDiagnostics, Inc. (CODX) Just Reclaimed the 20-Day Moving Average
11:26am, Monday, 16'th Aug 2021
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Why Co-Diagnostics Zoomed Almost 10% Higher Today
05:47pm, Friday, 13'th Aug 2021
The company notched beats on both trailing and anticipated revenue and earnings.
Co-Diagnostics Stock Moves Higher As Q2 Earnings Top Estimates
01:55pm, Friday, 13'th Aug 2021
Co-Diagnostics Inc's (NASDAQ: CODX) Q2 revenue increased 14% Y/Y to $27.4 million, primarily due to Logix Smart COVID-19 Test sales, beating the consensus of $20.77 million. Gross profit increased 3
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2021 Results - Earnings Call Transcript
10:02pm, Thursday, 12'th Aug 2021
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2021 Results - Earnings Call Transcript
CoDiagnostics, Inc. (CODX) Surpasses Q2 Earnings and Revenue Estimates
07:19pm, Thursday, 12'th Aug 2021
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 43.48% and 30.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics sees 2Q revenue rise by 13.8% driven by sales of the Logix Smart COVID-19 Test
04:34pm, Thursday, 12'th Aug 2021
Co-Diagnostics (NASDAQ:CODX) Inc posted second-quarter results that saw pre-tax income of $11.9 million and year-over-year revenue gains driven by sales of the company's Logix Smart COVID-19 Test. For
Analysts Estimate CoDiagnostics, Inc. (CODX) to Report a Decline in Earnings: What to Look Out for
04:44pm, Thursday, 05'th Aug 2021
CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast
11:30am, Wednesday, 04'th Aug 2021
SALT LAKE CITY, Aug. 4, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, a
